Cite
HARVARD Citation
Ryttberg, L. et al. (2011). Cost–effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden. Expert review of pharmacoeconomics & outcomes research. pp. 601-615. [Online].